Amarin (AMRN) says the FDA has not yet made a determination with respect to the regulatory...

|About: Amarin Corporation PLC (AMRN)|By:, SA News Editor

Amarin (AMRN) says the FDA has not yet made a determination with respect to the regulatory exclusivity of Vascepa, and has not included it in its mid-August update to its Orange Book, which is due on or about September 14, 2012. Shares -2.6% AH.